A carregar...

Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin

Eribulin mesylate was developed as a potent microtubule-targeting cytotoxic agent to treat taxane-resistant cancers, but recent clinical trials have shown that it eventually fails in many patient sub-populations for unclear reasons. To investigate its resistance mechanisms, we developed a fluorescen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Transl Med
Main Authors: Laughney, Ashley M., Kim, Eunha, Sprachman, Melissa M., Miller, Miles A., Kohler, Rainer H., Yang, Katy S., Orth, James D., Mitchison, Timothy J., Weissleder, Ralph
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4330962/
https://ncbi.nlm.nih.gov/pubmed/25378644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3009318
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!